Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions

References

• Fingar KR, Stocks C, Weiss AJ, et al. Most frequent operating room procedures performed in U.S. hospitals, 2003–2012: statistical brief #186. Healthcare Cost and Utilization Project (HCUP) statistical briefs. Rockville, MD: Agency for Healthcare Research and Quality (US), 2014, 1–15
   Google Scholar
• Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780–5
   PubMed Web of Science ®Google Scholar
• Bozic KJ, Ward L, Vail TP, et al. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res 2014;472:188–93
   PubMed Web of Science ®Google Scholar
• Kurtz SM, Lau E, Ong K, et al. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 2009;467:2606–12
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Vital Signs. Atlanta, GA: Arthritis in America. 2017. Available at: https://www.cdc.gov/vitalsigns/arthritis/index.html [Last accessed March 20, 2018]
   Google Scholar
• Centers for Medicare & Medicaid Services. New Medicare data available to increase transparency on hospital utilization. Baltimore, MD; 2015. Available at: https://www.cms.gov/newsroom/fact-sheets/new-medicare-data-available-increase-transparency-hospital-utilization [Last accessed February 12, 2018]
   Google Scholar
• Centers for Medicare & Medicaid Services. Comprehensive care for joint replacement model. Baltimore, MD; 2018. Available at: https://innovation.cms.gov/initiatives/cjr [Last accessed June 21, 2018]
   Google Scholar
• Centers for Medicare & Medicaid Services. BPCI Advanced. Baltimore, MD; 2018. Available at: https://innovation.cms.gov/initiatives/bpci-advanced [Last accessed July 6, 2018]
   Google Scholar
• Healy WL, Rana AJ, Iorio R. Hospital economics of primary total knee arthroplasty at a teaching hospital. Clin Orthop Relat Res 2011;469:87–94
   PubMed Web of Science ®Google Scholar
• Auyong DB, Allen CJ, Pahang JA, et al. Reduced length of hospitalization in primary total knee arthroplasty patients using an updated enhanced recovery after orthopedic surgery (ERAS) pathway. J Arthroplasty 2015;30:1705–9
   PubMed Web of Science ®Google Scholar
• Nichols CI, Vose JG. Clinical outcomes and costs within 90 days of primary or revision total joint arthroplasty. J Arthroplasty 2016;31:1400–06.e3
   PubMed Web of Science ®Google Scholar
• Jubelt LE, Goldfeld KS, Blecker SB, et al. Early lessons on bundled payment at an academic medical center. J Am Acad Orthop Surg 2017;25:654–63
   PubMed Web of Science ®Google Scholar
• Owens JM, Callaghan JJ, Duchman KR, et al. Short-term morbidity and readmissions increase with skilled nursing facility discharge after total joint arthroplasty in a Medicare-eligible and skilled nursing facility-eligible patient cohort. J Arthroplasty 2018;33:1343–7
   PubMed Web of Science ®Google Scholar
• Gerbershagen HJ, Aduckathil S, van Wijck AJ, et al. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology 2013;118:934–44
   PubMed Web of Science ®Google Scholar
• Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534–40
   PubMed Web of Science ®Google Scholar
• Baratta JL, Gandhi K, Viscusi ER. Perioperative pain management for total knee arthroplasty. J Surg Orthop Adv 2014;23:22–36
   PubMedGoogle Scholar
• Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res 2017;10:2287–98
   PubMed Web of Science ®Google Scholar
• Cherian JJ, Muzaffar A, Barrington JW, et al. Liposomal bupivacaine in total knee arthroplasty for better postoperative analgesic outcome and economic benefits. J Knee Surg 2016;29:180–7
   PubMed Web of Science ®Google Scholar
• Elmallah RK, Cherian JJ, Pierce TP, et al. New and common perioperative pain management techniques in total knee arthroplasty. J Knee Surg 2016;29:169–78
   PubMed Web of Science ®Google Scholar
• Oderda GM, Gan TJ, Johnson BH, et al. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother 2013;27:62–70
   PubMedGoogle Scholar
• Minkowitz HS, Gruschkus SK, Shah M, et al. Adverse drug events among patients receiving postsurgical opioids in a large health system: risk factors and outcomes. Am J Health Syst Pharm 2014;71:1556–65
   PubMed Web of Science ®Google Scholar
• Kessler ER, Shah M, Gruschkus SK, et al. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy 2013;33:383–91
   PubMed Web of Science ®Google Scholar
• Apold H, Meyer HE, Nordsletten L, et al. Risk factors for knee replacement due to primary osteoarthritis, a population based, prospective cohort study of 315,495 individuals. BMC Musculoskelet Disord 2014;15:217 [Epub]
   PubMedGoogle Scholar
• EXPAREL® (bupivacaine liposome injectable suspension). Full Prescribing Information. San Diego, CA: Pacira Pharmaceuticals, Inc., 2018
   Google Scholar
• Bergese SD, Ramamoorthy S, Patou G, et al. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res 2012;5:107–16
   PubMedGoogle Scholar
• Kuang MJ, Du Y, Ma JX, et al. The efficacy of liposomal bupivacaine using periarticular injection in total knee arthroplasty: a systematic review and meta-analysis. J Arthroplasty 2017;32:1395–402
   PubMed Web of Science ®Google Scholar
• Zlotnicki JP, Hamlin BR, Plakseychuk AY, et al. Liposomal bupivacaine vs plain bupivacaine in periarticular injection for control of pain and early motion in total knee arthroplasty: a randomized, prospective study. J Arthroplasty 2018;33:2460–4
   PubMed Web of Science ®Google Scholar
• Mont MA, Beaver WB, Dysart SH, et al. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty 2018;33:90–6
   PubMed Web of Science ®Google Scholar
• Chughtai M, Cherian JJ, Mistry JB, et al. Liposomal bupivacaine suspension can reduce lengths of stay and improve discharge status of patients undergoing total knee arthroplasty. J Knee Surg 2016;29:224–7
   PubMed Web of Science ®Google Scholar
• Cherian JJ, Barrington J, Elmallah RK, et al. Liposomal bupivacaine suspension can reduce length of stay and improve discharge status of patients undergoing total hip arthroplasty. Surg Technol Int 2015;27:235–9
   PubMedGoogle Scholar
• Howell DC, Rogier M, Yzerbyt V, et al. Statistical Methods in Human Sciences. New York: Wadsworth; 1998
   Google Scholar
• Corman S, Shah N, Dagenais S. Medication, equipment, and supply costs for common interventions providing extended post-surgical analgesia following total knee arthroplasty in US hospitals. J Med Econ 2018;21:11–18
   PubMed Web of Science ®Google Scholar
• Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med 2017;377:465–75
   PubMed Web of Science ®Google Scholar
• Snyder MA, Scheuerman CM, Gregg JL, et al. Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension. Arthroplast Today 2016;2:37–42
   PubMedGoogle Scholar
• Heim EA, Grier AJ, Butler RJ, et al. Use of liposomal bupivacaine instead of an epidural can improve outcomes following total knee arthroplasty. J Surg Orthop Adv 2015;24:230–4
   PubMedGoogle Scholar
• Emerson RH, Jr., Barrington JW, Olugbode O, et al. Femoral nerve block versus long-acting wound infiltration in total knee arthroplasty. Orthopedics 2016;39:e449–55
   PubMed Web of Science ®Google Scholar
• Barrington JW, Olugbode O, Lovald S, et al. Liposomal bupivacaine: a comparative study of more than 1000 total joint arthroplasty cases. Orthop Clin North Am 2015;46:469–77
   PubMed Web of Science ®Google Scholar
• Kirkness CS, Asche CV, Ren J, et al. Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty. Am J Health Syst Pharm 2016;73:e247–54
   PubMed Web of Science ®Google Scholar
• Yu S, Szulc A, Walton S, et al. Pain control and functional milestones in total knee arthroplasty: liposomal bupivacaine versus femoral nerve block. Clin Orthop Relat Res 2017;475:110–17
   PubMed Web of Science ®Google Scholar
• Surdam JW, Licini DJ, Baynes NT, et al. The use of Exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. J Arthroplasty 2015;30:325–9
   PubMed Web of Science ®Google Scholar
• Kim K, Elbuluk A, Yu S, et al. Cost-effective peri-operative pain management: assuring a happy patient after total knee arthroplasty. Bone Joint J 2018;100-B:55–61
   PubMedGoogle Scholar
• Broome CB, Burnikel B. Novel strategies to improve early outcomes following total knee arthroplasty: a case control study of intra articular injection versus femoral nerve block. Int Orthop 2014;38:2087–9
   PubMed Web of Science ®Google Scholar
• Pichler L, Poeran J, Zubizarreta N, et al. Liposomal bupivacaine does not reduce inpatient opioid prescription or related complications after knee arthroplasty: a database analysis. Anesthesiology 2018;129:689–99
   PubMed Web of Science ®Google Scholar
• Cozowicz C, Poeran J, Memtsoudis SG. Epidemiology, trends, and disparities in regional anaesthesia for orthopaedic surgery. Br J Anaesth 2015;115(Suppl 2):ii57–67
   PubMedGoogle Scholar